<DOC>
	<DOCNO>NCT00049140</DOCNO>
	<brief_summary>RATIONALE : Diagnostic procedure use drug EF5 detect presence oxygen tumor cell may help plan effective treatment solid tumor . PURPOSE : Phase II trial compare diagnostic procedure use EF5 method detect oxygen level tumor cell patient head neck cancer .</brief_summary>
	<brief_title>EF5 Compared With Other Methods Detecting Oxygen Levels Tumor Cells Patients With Head Neck Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine distribution , degree , intrapatient interpatient heterogeneity hypoxia , measure EF5 bind tumor tissue , patient head neck cancer . - Determine distribution intrapatient interpatient heterogeneity CA9 expression , measure immunohistochemically , patient . - Determine distribution , concentration , intrapatient interpatient heterogeneity glucose lactate , measure bioluminescence imaging , patient . - Determine whether spatial coordination concentration lactate glucose location tissue hypoxia patient . - Determine whether spatial coordination location CA9 hypoxia and/or lactate concentration patient . OUTLINE : Patients receive EF5 IV 1-2.5 hour day 1 . Within 24-55 hour EF5 infusion , patient undergo surgery . Tumor tissue sample examine EF5 bind immunohistochemistry , bioluminescence imaging , flow cytometry . Patients follow 1 month survival . PROJECTED ACCRUAL : Approximately 20 patient accrue study within 1 year .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm squamous cell carcinoma head neck Clinically detectable disease physical examination radiographic study Scheduled undergo surgical resection tumor radiotherapeutic treatment PATIENT CHARACTERISTICS : Age 18 Performance status Karnofsky 70100 % Life expectancy Not specify Hematopoietic WBC great 3,000/mm^3 Platelet count great 100,000/mm^3 Hepatic Bilirubin great 1.5 mg/dL Renal Creatinine great 1.8 mg/dL Other No allergy IV contrast dye No prior grade III IV peripheral neuropathy Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception 1 week study participation PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy Not specify Endocrine therapy Not specify Radiotherapy See Disease Characteristics Concurrent radiotherapy allow Surgery See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>stage I squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage I squamous cell carcinoma larynx</keyword>
	<keyword>stage I squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage I squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage I squamous cell carcinoma oropharynx</keyword>
	<keyword>stage I squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>stage II squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage II squamous cell carcinoma larynx</keyword>
	<keyword>stage II squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage II squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage II squamous cell carcinoma oropharynx</keyword>
	<keyword>stage II squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>stage III squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage III squamous cell carcinoma larynx</keyword>
	<keyword>stage III squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage III squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage III squamous cell carcinoma oropharynx</keyword>
	<keyword>stage III squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>stage IV squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma larynx</keyword>
	<keyword>stage IV squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IV squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IV squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>stage I salivary gland cancer</keyword>
	<keyword>stage II salivary gland cancer</keyword>
	<keyword>stage III salivary gland cancer</keyword>
	<keyword>stage IV salivary gland cancer</keyword>
	<keyword>salivary gland squamous cell carcinoma</keyword>
</DOC>